8-KEarnings & ResultsExhibits & Filings

QUEST DIAGNOSTICS INC 8-K Report, Financial Results (Jan 26, 2006)

Filed January 26, 2006For Securities:DGX

Summary

Quest Diagnostics Incorporated (DGX) filed an 8-K on January 26, 2006, to report its financial results for the fourth quarter and full twelve months ended December 31, 2005. This filing primarily serves to furnish a press release detailing these results, which is incorporated by reference into the report. Investors should refer to the attached press release (Exhibit 99.1) for specific financial performance metrics, including revenue, earnings per share, and any forward-looking statements or guidance provided by the company. While the 8-K itself is a procedural filing, the attached press release contains the substantive financial information that is crucial for understanding Quest Diagnostics' recent performance. Investors are encouraged to review this press release for details on operational achievements, financial condition, and any other significant announcements made by the company in relation to its 2005 year-end results.

Key Highlights

  • 1Quest Diagnostics (DGX) filed an 8-K on January 26, 2006, reporting Q4 and FY 2005 financial results.
  • 2The filing incorporates by reference a press release (Exhibit 99.1) containing the detailed financial results.
  • 3Investors need to consult the referenced press release for specific financial performance data.
  • 4The report covers the twelve months and the quarter ended December 31, 2005.
  • 5The filing is a standard regulatory update to inform the market of the company's financial outcomes.
  • 6Robert A. Hagemann, Senior Vice President and Chief Financial Officer, signed the report.

Frequently Asked Questions

The main purpose of this 8-K filing is to officially report Quest Diagnostics' financial results for the fourth quarter and the full fiscal year ended December 31, 2005, to the Securities and Exchange Commission (SEC). It formally incorporates a press release that contains the detailed financial information.

The specific financial results are not detailed within the 8-K filing itself. They are provided in the press release attached as Exhibit 99.1, which is incorporated by reference into this report. Investors should review this press release for comprehensive financial data.

These financial results cover the fourth quarter and the full twelve months of the fiscal year that ended on December 31, 2005.

The report was signed by Robert A. Hagemann, Senior Vice President and Chief Financial Officer of Quest Diagnostics Incorporated.